Humira for the Treatment of Hidradenitis Suppurativa
Humira (adalimumab) is a monoclonal antibody indicated for the treatment of more than...
Trending menu:
-
![]()
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
-
![]()
Rozlytrek (entrectinib) for the Treatment of Solid Cancerous Tumours
-
![]()
Zynteglo for the Treatment of Transfusion-Dependent Beta-thalassemia
-
![]()
Piqray (alpelisib) for the Treatment of Advanced Breast Cancer
-
![]()
Polivy (polatuzumab vedotin) for the Treatment of Diffuse Large B-cell Lymphoma
-
![]()
Zolgensma for the Treatment of Spinal Muscular Atrophy
Most Read
Latest Content
Manufacturers Choose the Mastersizer 3000 for Accuracy and Efficiency
In 2016, Metals and Additives LLC, a leading manufacturer and supplier of powder additives for the battery and plastics industries, purchased the Mastersizer 3000 from Malvern Panalytical.
AtreMorine for Parkinson’s Disease and Dopamine-Related Disorders
AtreMorine is a novel biopharmaceutical compound obtained through non-denaturing biotechnological procedures from the structural components of the Vicia faba L plant, for the prevention and treatment of Parkinson´s disease (PD) and related disorders.
Secuado (asenapine) for the Treatment of Schizophrenia
Secuado® (asenapine) is an atypical anti-psychotic drug approved for the treatment of schizophrenia in adult patients. It is the first drug approved as transdermal patch formulation for schizophrenia treatment in the US.
JYNNEOS Vaccine for the Prevention of Smallpox and Monkeypox
JYNNEOS™ is a non-replicating vaccine indicated for smallpox and monkeypox disease prevention in adults aged 18 years and older.
Myobloc (rimabotulinumtoxinB) for the Treatment of Chronic Sialorrhea
Myobloc® (rimabotulinumtoxinB) is the first neurotoxin approved for the treatment of chronic sialorrhea in adults.
Vyvanse® (lisdexamfetamine) for the Treatment of Binge-Eating Disorder
Vyvanse® (lisdexamfetamine dimesylate) is a central nervous system (CNS) stimulant indicated for the treatment of moderate-to-severe binge-eating disorder and attention deficit hyperactivity disorder (ADHD).
Signant Health launches partner programme to improve clinical trials
Zelboraf is indicated for the treatment of metastatic melanoma and Erdheim-Chester disease.
Soliris – Treatment for PNH, aHUS, gMG, and NMOSD
Soliris (eculizumab) is a drug indicated for the treatment of paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uremic syndrome (aHUS), generalised myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).
Humira for the Treatment of Hidradenitis Suppurativa
Humira (adalimumab) is a monoclonal antibody indicated for the treatment of more than ten indications, including rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa (HS), and uveitis.
June’s top news stories
AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial in first-line extensive-stage small cell lung cancer (SCLC).
Latest News
Close
Close
Close
Go Top
